Xtant Medical
1998
FOUNDED
PUBLIC
STATUS
101-200
EMPLOYEES
XTNT
STOCK SYMBOL
3
INVESTMENTS
$2.51
SHARE PRICE
(As of Friday Closing)
Description
Xtant Medical Holdings Inc mainly develops, manufactures and markets regenerative medicine products and medical devices for domestic and international markets. The company operates through the single segment of Development, manufacture, and marketing of regenerative medical products and devices. Its biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect DBM putty, OsteoSelect Plus DBM putty, OsteoWrap, BacFast HD, OsteoSTX, hMatrix and 3Demin products, as well as other allografts. Its products serve the needs of orthopedic and neurological surgeons, including orthobiologics for the promotion of bone healing, implants, and instrumentation for the treatment of spinal disease, tissue grafts for the treatment of orthopedic disorders and others.
Formerly Known As
Bacterin International
Ownership Status
Publicly Held
Financing Status
Corporate Backed or Acquired
Primary Industry
Therapeutic Devices
Other Industries
Other Devices and Supplies
Stock Exchange
ASE
Primary Office
- 664 Cruiser Lane
- Belgrade, MT 59714
- United States
+1 (888) 000-0000
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Xtant Medical’s full profile, request a free trial.
Xtant Medical Stock Performance
| 52 wk Range | Market Cap | Prev. Close | EPS | Average Volume | Shares |
|---|---|---|---|---|---|
| $1.61 - $4.88 | $33M | $2.42 | -$4.91 | 2.92K | 13.2M |
Xtant Medical Financials Summary
|
In Thousands,
USD |
TTM
30-Jun-2019
|
FY 2018
31-Dec-2018
|
FY 2017
31-Dec-2017
|
FY 2016
31-Dec-2016
|
|---|---|---|---|---|
| Enterprise Value | 108,139 | 92,815 | 145,703 | 135,720 |
| Revenue | 67,525 | 72,203 | 82,612 | 90,003 |
| EBITDA | (52,517) | (53,364) | (29,297) | 61 |
| Net Income | (64,582) | (70,099) | (52,411) | (19,494) |
| Total Assets | 44,497 | 46,422 | 105,705 | 144,102 |
| Total Debt | 76,491 | 78,569 | 138,952 | 130,747 |
Public Fundamental Data provided by Morningstar, Inc.
disclaimer
Xtant Medical Valuation and Funding
| Deal Type | Date | Amount | Post-Val | Valuation/ EBITDA |
Debt | Status |
|---|
This information is reserved for PitchBook Platform users. To explore Xtant Medical‘s full profile, request access.
Request full access to PitchBookXtant Medical Competitors (10)
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Misonix | Corporation | Farmingdale, NY | 000 | |||
| 000000 000000 | Corporation | Warsaw, IN | 00000 | 00.000 | 000000000 | 00.000 |
| 00000000 | Corporation | Carlsbad, CA | 000 | 00000000. 00 | ||
| 000000 0000000 | Formerly VC-backed | Audubon, PA | 0000 | 00000 | 00000000000 | 00000 |
| 000000000 | Corporation | Minneapolis, MN | 00000 | 00000000 |
Xtant Medical Acquisitions (3)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| 0-00000 0000000 | 31-Jul-2015 | 000000000000000000 | 000.00 | Therapeutic Devices | 000000 0000000000 |
| 00000000 0000000 | 18-Jul-2011 | 000000000000000000 | 000 | Surgical Devices | 000 0000 |
| Ace Oil & Gas | 24-Oct-2007 | Merger/Acquisition | Energy Exploration |
Xtant Medical Investors
| Investor Name | Investor Type | Holding | Participating Rounds | Investor Since | Board Seat | Contact Info |
|---|
This information is reserved for PitchBook Platform users. To explore Xtant Medical‘s full profile, request access.
Request full access to PitchBookXtant Medical Executive Team (18)
12 Former Executives
You’re viewing 5 of 18 executives. Get the full list »Xtant Medical Board Members (11)
| Name | Representing | Role | Since | Contact Info |
|---|---|---|---|---|
| 0000 00000000 | Xtant Medical | Board Member | 000 0000 | |
| 0000 00000000 | Self | Board Member | 000 0000 | |
| 0000 000000 | Self | Board Member | 000 0000 |
8 Former Board Members
You’re viewing 3 of 11 board members. Get the full list »